These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28976297)

  • 21. A model of the effects of cancer cell motility and cellular adhesion properties on tumour-immune dynamics.
    Frascoli F; Flood E; Kim PS
    Math Med Biol; 2017 Jun; 34(2):215-240. PubMed ID: 27094601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability and Hopf bifurcation for a five-dimensional virus infection model with Beddington-DeAngelis incidence and three delays.
    Miao H; Teng Z; Abdurahman X
    J Biol Dyn; 2018 Dec; 12(1):146-170. PubMed ID: 29198164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Clearance Analysis on a Cancer Chemo-Immunotherapy Mathematical Model.
    Valle PA; Coria LN; Salazar Y
    Bull Math Biol; 2019 Oct; 81(10):4144-4173. PubMed ID: 31264136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
    Barbarossa MV; Kuttler C; Zinsl J
    Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodic and chaotic oscillations in a tumor and immune system interaction model with three delays.
    Bi P; Ruan S; Zhang X
    Chaos; 2014 Jun; 24(2):023101. PubMed ID: 24985415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the optimal therapeutic protocols in cancer immunotherapy.
    Cappuccio A; Castiglione F; Piccoli B
    Math Biosci; 2007 Sep; 209(1):1-13. PubMed ID: 17416392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the global dynamics of a model for tumor immunotherapy.
    Kirschner D; Tsygvintsev A
    Math Biosci Eng; 2009 Jul; 6(3):573-83. PubMed ID: 19566127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of the cell-mediated immune response to tumour growth.
    López ÁG; Seoane JM; Sanjuán MAF
    Philos Trans A Math Phys Eng Sci; 2017 Jun; 375(2096):. PubMed ID: 28507236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of equilibria and effects of drug treatments in some simple viral population dynamical models.
    Tuckwell HC; Wan FY
    IMA J Math Appl Med Biol; 2000 Dec; 17(4):311-27. PubMed ID: 11270747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A delay-differential equation model of HIV related cancer-immune system dynamics.
    Foryś U; Poleszczuk J
    Math Biosci Eng; 2011 Apr; 8(2):627-41. PubMed ID: 21631150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability analysis of pathogen-immune interaction dynamics.
    Murase A; Sasaki T; Kajiwara T
    J Math Biol; 2005 Sep; 51(3):247-67. PubMed ID: 15868196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model.
    Doban AI; Lazar M
    Math Biosci; 2017 Feb; 284():40-50. PubMed ID: 27665680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
    de Pillis LG; Gu W; Radunskaya AE
    J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling cancer-immune responses to therapy.
    dePillis LG; Eladdadi A; Radunskaya AE
    J Pharmacokinet Pharmacodyn; 2014 Oct; 41(5):461-78. PubMed ID: 25281420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.
    Konstorum A; Vella AT; Adler AJ; Laubenbacher RC
    J R Soc Interface; 2017 Jun; 14(131):. PubMed ID: 28659410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamical analysis on a chronic hepatitis C virus infection model with immune response.
    Li J; Men K; Yang Y; Li D
    J Theor Biol; 2015 Jan; 365():337-46. PubMed ID: 25451526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of an in vitro chemotherapy to avoid resistant tumours.
    Carrère C
    J Theor Biol; 2017 Jan; 413():24-33. PubMed ID: 27864095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapeutic potential of whole tumour cells.
    Ward S; Casey D; Labarthe MC; Whelan M; Dalgleish A; Pandha H; Todryk S
    Cancer Immunol Immunother; 2002 Sep; 51(7):351-7. PubMed ID: 12192534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.
    Ledzewicz U; Olumoye O; Schättler H
    Math Biosci Eng; 2013 Jun; 10(3):787-802. PubMed ID: 23906150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of chemo-therapy on optimal control of malaria disease with infected immigrants.
    Makinde OD; Okosun KO
    Biosystems; 2011 Apr; 104(1):32-41. PubMed ID: 21219965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.